Moleculin Biotech (MBRX) Tops Q1 EPS by 1c

Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan